To land a job in a competitive field, graduates must go beyond the obvious and prepare extensively, adbises Vijay Gupta, director-global human resources, Rahi Sytems, a global IT services and solutions company.
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.
Prime Minister Narendra Modi and his Belgian counterpart Charles Michel remotely launched Asia's biggest telescope, the ARIES, built with Belgian assistance.
...with extravagant claims in both the eastern and western sectors, observes Ambassador Talmiz Ahmad, as India is fixated on asserting its border claims based on the McMahon Line.
In a statement Bharat Biotech clarified that the vaccine's efficacy can only be determined 14 days after the second dose.
'The pressure to work together is even greater than before, because the Chinese have launched a full-court press on the border, in the region, and globally to advance their geopolitical agenda.'
'The most intriguing thing (about COVID-19) is the range of the illness -- from asymptomatic or less symptoms to death and quite severe manifestations.' 'The vaccine will be at least another year away from having any effect.'
Chaos prevailed outside a newly-inaugurated 900-bed Covid-19 hospital in Ahmedabad as people flocked there in large numbers since early morning on Thursday with the hope of securing admission for their ailing family members and relatives.
India will be the fourth country after the United States, Russia and China to send humans to space.
The researchers, working in an 'unprecedented' vaccine development effort to prevent COVID-19, said they have started screening healthy volunteers (aged 18-55) from Friday for their upcoming trial in the Thames Valley Region of England.
An impulsive decision to resign could eventually turn out to be a big career mistake, warns Srividya Kannan.
India has received over USD 20 billion in FDI amid the coronavirus pandemic, Foreign Secretary Harsh Vardhan Shringla said on Tuesday, showcasing the country as one of the most attractive destinations for investment globally.
"Somewhat surprisingly, Indian-Americans born in the United States are much more likely to report being victims of discrimination than their foreign-born counterparts," said the report.
The phase 3 clinical trial will cover around 28,500 subjects, aged 18 years and above, and it will be conducted in 21 sites across ten states, including Delhi, Mumbai, Patna and Lucknow.
Global pharmaceutical major Teva is planning collaborations with Indian partners for clinical research and biotechnology.
India's largest oil firm IOC will build the nation's first 'green hydrogen' plant at its Mathura refinery, as it aims to prepare for a future catering to the growing demand for both oil and cleaner forms of energy. Indian Oil Corporation (IOC) has drawn a strategic growth path that aims to maintain focus on its core refining and fuel marketing businesses while making bigger inroads into petrochemicals, hydrogen and electric mobility over the next 10 years, its chairman Shrikant Madhav Vaidya said. The company will not set captive power plants at all its future refinery and petrochemical expansion projects and instead use the 250 MW of electricity it produces from renewable sources like solar power, he told PTI in an interview.
The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
The new vaccine candidate, DIOS-CoVax2, uses banks of genetic sequences of all known coronaviruses, including those from bats, believed to be the natural hosts of many relatives of human coronaviruses.
Highlighting the role of MSMEs in enhancing exports and helping the country achieve self reliance, Union Minister Nitin Gadkari on Monday said India does not need to import from China. "Already in automobile sector, in many sectors now, in agriculture, automobiles, everywhere, we have already found the solutions. Now we don't need to import from China," said the minister. He observed that India was exporting a lot of items instead of importing them.
'The government wants farmers to diversify from rice and wheat, and create another green revolution. Cannabis can play a big part in that'
Tata Consultancy Services on Monday entered into a five year research and development collaboration with Stanford University of United States for research in the critical area of data privacy.
The centre will be focusing on emerging communication technologies
India's leading drug maker Ranbaxy Laboratories is likely to announce a drug discovery research tie-up with US drug manufacturer Merck soon. Ranbaxy's ongoing research collaboration with GSK also relates to the pre-clinical trial phase of the new drug, with significant milestone payment and post-commercialisation royalty possibilities. Ranbaxy's decision to de-merge its research operations was intended at having more collaborative research programmes involving foreign firms.
Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said the government attaches 'great importance to this offer of partnership from a very special friend to this nation'.
Describing the trial a "complete success", sources said that all the mission objectives were met during the test.
The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services, which aims at accelerating the development and manufacturing of medical countermeasures for COVID-19 and delivering 300 million doses of an effective vaccine by January 2021.
Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.
US auto major Ford Motor Co on Friday said it and India's Mahindra & Mahindra have decided to scrap their previously announced automotive joint venture and it will continue its independent operations in India as it is. The two companies determined that they will not complete a previously announced automotive joint venture between their respective companies. The decision follows the passing of the December 31, 2020 'longstop' or expiration date of a definitive agreement the organisations entered into in October 2019, Ford Motor Company said in a statement.
Paul Herrling, global head of Novartis' corporate research, spoke to Business Standard about the changing concepts in R&D and Novartis' strategy.
These companies were identified through the India Innovation Growth Programme, an innovation contest through which the US firm identifies Indian research and development potential.
'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'
An alert government in Delhi should have begun government-to-government discussions with Moscow the moment it came to know that Russians were developing a vaccine. That is to say, almost an year's time has been lost, observes Ambassador M K Bhadrakumar.
Medical experts have warned that the volume of vaccine available to fight the coronavirus or SARS-CoV-2 in coming years is expected to fall far short of global demand, despite an unprecedented effort to manufacture billions of doses.
The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.
Advantages are not being leveraged fully mainly because of lack of funds, say experts.
The new project will be associated with research themes featuring the exploration of transportation means, energy and food on the Red Planet.
India's scores low due to poor quality of its political, regulatory, and business environment.
The UK will now be taking forward a solution that brings together the work on the National Health Service app and the Google/Apple solution.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances